Invention Grant
US07662750B2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
失效
基于1,4-二取代萘和相关支架的蛋白质 - 蛋白质相互作用拮抗剂筛选文库
- Patent Title: Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
- Patent Title (中): 基于1,4-二取代萘和相关支架的蛋白质 - 蛋白质相互作用拮抗剂筛选文库
-
Application No.: US11005194Application Date: 2004-12-06
-
Publication No.: US07662750B2Publication Date: 2010-02-16
- Inventor: David G. Hangauer , Tao Ji , Madison Lee , Steven Pruitt
- Applicant: David G. Hangauer , Tao Ji , Madison Lee , Steven Pruitt
- Applicant Address: US NY Amherst US NY Buffalo
- Assignee: The Research Foundation of State University of New York,Roswell Park Cancer Institute
- Current Assignee: The Research Foundation of State University of New York,Roswell Park Cancer Institute
- Current Assignee Address: US NY Amherst US NY Buffalo
- Agency: Nixon Peabody LLP
- Main IPC: C40B40/16
- IPC: C40B40/16

Abstract:
The present invention relates to 1,4-disubstituted naphthalene scaffold compounds and other closely related scaffold compounds. The present invention also relates to combinatorial libraries of such compounds. In addition, the present invention relates to a method of identifying a protein-protein interaction antagonist. The method first involves providing a compound as described herein. Next, the compound is contacted with interacting proteins of a protein-protein interaction target complex, whereby the compound is allowed to compete with the interacting proteins. Then, the activity of the compound for inhibiting formation of the protein-protein interaction target complex is measured. Finally, the compound that inhibits formation of the protein-protein interaction target complex is identified as a protein-protein interaction antagonist. Also disclosed is a method for modulating a protein-protein interaction. The method involves contacting interacting proteins of a protein-protein interaction target with a compound as described herein, whereby the protein-protein interaction between the interacting proteins is modulated.
Public/Granted literature
Information query